Physician profile
William David Moore
NPI 1891759312
$1,584.04
in general payments reported to CMS, 2019-2025
20 companies · $418 in 2025
The $418 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $151 · 2021: $147 · 2022: $296 · 2023: $213 · 2024: $237 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $358.01 | 2019-2025 | Bexsero, Rotarix, Menveo |
| Sanofi Pasteur INC. | $160.99 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $153.78 | 2019-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Cranial Technologies, INC | $150.13 | 2021-2025 | Doc Band |
| Amgen INC. | $123.48 | 2025 | Otezla |
| Janssen Biotech, INC. | $120.80 | 2025 | Tremfya, Simponi Aria |
| Pfizer INC. | $87.83 | 2019-2025 | |
| Kaleo, INC. | $85.14 | 2020-2024 | Auvi-Q |
| Hologic Sales and Service, LLC | $62.13 | 2025 | Aptima |
| Biogen, INC. | $40.11 | 2022-2023 | Spinraza |
| Astrazeneca Pharmaceuticals LP | $38.14 | 2023-2024 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $37.37 | 2022 | |
| Alk-Abello, INC | $37.21 | 2021-2022 | |
| Adlon Therapeutics L.P. | $28.27 | 2019 | |
| Verrica Pharmaceuticals INC. | $25.93 | 2025 | Ycanth |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $16.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.93 | 2019 | |
| Seqirus USA INC | $14.89 | 2024 | Flucelvax |
| Companion Medical, INC. | $14.80 | 2019 | |
| Galen US INC | $13.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.